distance between thin and thick vertical bars represents tail length; black curve = average comet profile; light grey curve = DNA in head; dark grey curve = DNA in tail). Individual comet images were normalized for total fluorescent intensity, thereby making each comet image directly comparable in terms of %DNA content and subsequent Olive tail moment (%DNA in tail x tail length). Normalization does not affect the tail length values. The 75 normalized images (comets) for each sample were then averaged into their respective composite image. The composite image and its comet profile (all of which have the same area under the curve) directly reflects the average Olive tail moment for that sample. In parts A and B, DNA-damaged lysates are shown (t1, pink line). In parts C, D and E control lysates that were not treated are shown (blue line). A star indicates the peaks that are in common for all antibodies and are specific for RPA isoforms under these experimental conditions.
Supplementary Figure S3.
To make sure the RPA2(pS29) antibody was active we tested against mitotic cell lysates as a positive control. UM-SCC-38 WT RPA cells synchronized to M phase with nocodazole were harvested and lysed. Whole cell lysate was separated on a 10% Bis-Tris SDS PAGE gel. Proteins were transferred to a nitrocellulose membrane and probed with anti-RPA2(pS29). Protein loaded left to right: 10 µg, 20 µg, 40 µg. Thus, the antibody sample is good and the lack of signal in the westerns is due to very low levels of RPA2(pS29). Treatments: CPT = camptothecin; ETOP = etoposide; HU=hydroxyurea; IR=ionizing radiation; PMA = phorbol 12-myristate 13-acetate Kinase: PIKK = ATM/ATR or DNA-PKcs; CDK = cyclin dependent kinase; CHK = checkpoint homolog kinase, CK = casein kinase, GSK = glycogen synthase kinase 
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